DaVita (NYSE: DVA)
DaVita Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
DaVita Company Info
DaVita, Inc. engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consist primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.
News & Analysis
Why DaVita Stock Withered on Wednesday
The company's profitability is going in the wrong direction for many investors.
These Warren Buffett Stocks Are Trouncing the S&P 500 so Far This Year. Are They Still Buys?
Buffett no doubt likes what he's seeing with these high-flying stocks.
Warren Buffett's 3 Best-Performing Stocks So Far in 2024: Are They Buys Now?
These high-flying Buffett stocks could be attractive to different kinds of investors.
Why DaVita Stock Popped Today
The dialysis services company handily beat expectations with its latest quarter.
Meet the Most Ridiculously Cheap Stock in Warren Buffett's Berkshire Hathaway Portfolio
This stock isn't cheap because it's performed poorly over the past 12 months.
2 Best Warren Buffett Stocks to Buy for the Long Haul
You don't need to have millions of dollars to invest in quality businesses.
Why Shares of DaVita Were Up Tuesday
The dialysis company's raised guidance encouraged investors.
Down 26%, Is This Buffett Stock a Buy?
Warren Buffett loves to own cash-generating "toll bridge" companies. DaVita qualifies on both counts.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.